FRONTIER CAPITAL MANAGEMENT CO LLC
Position in PRCT — PROCEPT BioRobotics Corp
CIK 351173
Boston, MA
Position in PRCT
as of Jun 30, 2026
· filed Aug 14, 2026
Position Value
$24,646,702
+$9,394,179 QoQ
Shares Held
1,091,528
+79.0% QoQ
Ownership
1.91%
of shares outstanding
% of Portfolio
0.23%
of 13F equity value
Holder Rank
#14
of 254 holders
Holding Since
Dec 2024
7 quarters on record
Voting authority
Sole 35%
Shared 0%
None 65%
Common Shares in PRCT Over Time
Shares Held
Position Value (USD)
Position in Medical Devices
Healthcare · as of Jun 30, 2026FRONTIER CAPITAL MANAGEMENT CO LLC holds $223,011,989 across 9 Medical Devices names. PRCT ranks #3 (11.1% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | PODD |
Insulet Corp
|
622,506 | $94,776,538 | |
| 2 | DXCM |
Dexcom Inc
|
547,220 | $36,855,267 | |
| 3 | PRCT |
PROCEPT BioRobotics Corp
This page
|
1,091,528 | $24,646,702 | |
| 4 | STE |
STERIS plc
|
92,310 | $19,437,716 | |
| 5 | IRTC |
iRhythm Holdings, Inc.
|
132,475 | $15,757,901 | |
| 6 | GEHC |
GE HealthCare Technologies Inc.
|
160,021 | $10,242,944 | |
| 7 | TMDX |
TransMedics Group, Inc.
|
150,162 | $9,973,760 | |
| 8 | TNDM |
Tandem Diabetes Care Inc
|
380,458 | $5,741,111 |
All Filings in PRCT
Export CSV
7 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $24,646,702 | 1,091,528 | Shares | Sole | 2026-08-14 | |
| 2026-03-31 | $15,252,523 | 609,857 | Shares | Sole | 2026-05-15 | |
| 2025-12-31 | $7,367,302 | 234,180 | Shares | Sole | 2026-02-17 | |
| 2025-09-30 | $3,764,152 | 105,468 | Shares | Sole | 2025-11-14 | |
| 2025-06-30 | $24,114,700 | 418,658 | Shares | Sole | 2025-08-14 | |
| 2025-03-31 | $12,529,162 | 215,056 | Shares | Sole | 2025-05-15 | |
| 2024-12-31 | $18,145,343 | 225,352 | Shares | Sole | 2025-02-14 | |
| No filing history on record for this holder in this stock. | ||||||